Cargando…

Duration of anti-tuberculous therapy in children with persistent tuberculomas

The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Ira, Shetty, Naman S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329029/
https://www.ncbi.nlm.nih.gov/pubmed/30671250
http://dx.doi.org/10.1177/2050313X18823092
_version_ 1783386753101463552
author Shah, Ira
Shetty, Naman S
author_facet Shah, Ira
Shetty, Naman S
author_sort Shah, Ira
collection PubMed
description The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of six cases of children with central nervous system tuberculosis who received anti-tuberculous therapy for a period varying between 23 and 32 months depending on the resolution of lesion seen in neuroradiological scans of the patients. Decrease in number and size of granuloma were noted in all patients while one patient showed complete resolution. After stopping anti-tuberculous therapy, the size of the granuloma remained the same, while in one patient an increase was noted. Thus, the duration of anti-tuberculous therapy in patients with tuberculoma may vary and may be required for longer time based on treatment response.
format Online
Article
Text
id pubmed-6329029
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-63290292019-01-22 Duration of anti-tuberculous therapy in children with persistent tuberculomas Shah, Ira Shetty, Naman S SAGE Open Med Case Rep Case Report The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of six cases of children with central nervous system tuberculosis who received anti-tuberculous therapy for a period varying between 23 and 32 months depending on the resolution of lesion seen in neuroradiological scans of the patients. Decrease in number and size of granuloma were noted in all patients while one patient showed complete resolution. After stopping anti-tuberculous therapy, the size of the granuloma remained the same, while in one patient an increase was noted. Thus, the duration of anti-tuberculous therapy in patients with tuberculoma may vary and may be required for longer time based on treatment response. SAGE Publications 2019-01-09 /pmc/articles/PMC6329029/ /pubmed/30671250 http://dx.doi.org/10.1177/2050313X18823092 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Shah, Ira
Shetty, Naman S
Duration of anti-tuberculous therapy in children with persistent tuberculomas
title Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_full Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_fullStr Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_full_unstemmed Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_short Duration of anti-tuberculous therapy in children with persistent tuberculomas
title_sort duration of anti-tuberculous therapy in children with persistent tuberculomas
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329029/
https://www.ncbi.nlm.nih.gov/pubmed/30671250
http://dx.doi.org/10.1177/2050313X18823092
work_keys_str_mv AT shahira durationofantituberculoustherapyinchildrenwithpersistenttuberculomas
AT shettynamans durationofantituberculoustherapyinchildrenwithpersistenttuberculomas